C94.0
Acute erythroid leukemia
Clinical Classification Guidelines
Inclusion Terms
- Acute myeloid leukemia M6(a)(b)
- Erythroleukemia
Medical Intelligence & Overview
Acute erythroid leukemia, also known as erythroleukemia, is a rare and serious type of blood cancer that affects the bone marrow—the soft tissue inside bones where blood cells are produced. Characterized by the rapid growth of abnormal erythroid and myeloid cells, this condition disrupts normal blood cell production, leading to a range of health issues. Recognized under ICD-10 code C94.0, this leukemia requires prompt medical attention for diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal blood cell development Exposure to radiation or certain chemotherapy drugs Pre-existing blood disorders such as myelodysplastic syndromes Environmental toxins like benzene Family history of blood cancers
Key Symptoms: Fatigue and weakness due to anemia Pale skin and mucous membranes Frequent or severe infections because of a low white blood cell count Easy bruising or bleeding caused by low platelet levels Unexplained fever or weight loss Bone pain or tenderness
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute erythroid leukemia involves multiple steps to confirm the presence of abnormal blood cells. Blood tests will often reveal anemia, abnormal white blood cell counts, and low platelets. A bone marrow biopsy is crucial, as it allows doctors to examine the marrow tissue directly, identifying the proliferation of immature erythroid and myeloid cells characteristic of the disease. Additional tests might include cytogenetic analysis to detect genetic abnormalities linked to the leukemia.
Treatment Protocols: Treatment options aim to destroy abnormal cells and restore healthy blood production. Common approaches include chemotherapy, which uses powerful drugs to target rapidly dividing cells, and may be combined with supportive therapies like blood transfusions to manage anemia. In some cases, stem cell or bone marrow transplants are considered, especially for eligible patients, to replace diseased marrow with healthy donor cells. Supportive care to prevent infections, manage bleeding, and address symptoms is also an essential part of treatment. Because of the aggressive nature of this leukemia, treatment plans are tailored to each patient's overall health and disease progression.
Clinical Advice & FAQs
Billing Guidance
Is C94.0 a billable ICD-10 code?
Yes, C94.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.0?
Clinical documentation must specify the nature of Acute erythroid leukemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
